Three US Fingolimod Approvals Raise Legal Stakes

Approvals for Biocon, HEC and Sun Pharma

 
• By Aidan Fry

The first three FDA approvals for generic fingolimod generics come amid ongoing legal uncertainty over Novartis’ Gilenya blockbuster multiple sclerosis treatment.

Bollards
Three fingolimod generics have been approved in the US, but legal issues may block their path to market • Source: Shutterstock

More from Products

More from Generics Bulletin